Avandaryl Interactions
There are 511 drugs known to interact with Avandaryl (glimepiride/rosiglitazone), along with 14 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 28 are major, 468 are moderate, and 15 are minor.
- View all 511 medications that may interact with Avandaryl
- View Avandaryl alcohol/food interactions (4)
- View Avandaryl disease interactions (14)
Most frequently checked interactions
View interaction reports for Avandaryl (glimepiride / rosiglitazone) and the medicines listed below.
- Advicor (lovastatin / niacin)
- Advicor (lovastatin / niacin)
- Amaryl (glimepiride)
- Amaryl (glimepiride)
- amlodipine
- amlodipine
- Aspirin Low Strength (aspirin)
- Aspirin Low Strength (aspirin)
- Avandia (rosiglitazone)
- Avandia (rosiglitazone)
- Crestor (rosuvastatin)
- Crestor (rosuvastatin)
- furosemide
- furosemide
- gabapentin
- gabapentin
- Lipitor (atorvastatin)
- Lipitor (atorvastatin)
- lisinopril
- lisinopril
- Lyrica (pregabalin)
- Lyrica (pregabalin)
- metformin
- metformin
- Singulair (montelukast)
- Singulair (montelukast)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vytorin (ezetimibe / simvastatin)
- Vytorin (ezetimibe / simvastatin)
Avandaryl alcohol/food interactions
There are 4 alcohol/food interactions with Avandaryl (glimepiride / rosiglitazone).
Avandaryl disease interactions
There are 14 disease interactions with Avandaryl (glimepiride / rosiglitazone) which include:
- cardiovascular risk
- myocardial infarction
- renal/liver disease
- CHF
- type I diabetes
- hypoglycemia
- G6PD deficiency
- hyponatremia
- edema
- liver disease
- macular edema
- premenopausal anovulation
- weight gain
- anemia
More about Avandaryl (glimepiride / rosiglitazone)
- Avandaryl consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiabetic combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.